1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Prepare yourself for social engineering and identity politics

Discussion in 'Celgene' started by anonymous, Jan 3, 2019 at 6:52 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Telling ya. Fhags, gays, and transmestmites everywhere now.
     
  2. anonymous

    anonymous Guest

    After reading the above posts, I can see that BMS is getting the “mental cream of the crop” sales team at Celgene. I hope, that those of you who have posted the disparaging remarks above are expecting to be let go...because you will be. Celgene is better than this thread implies.